Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus

por Hövelmann, Ulrike, Olsen, Minna Brændholt, Mouritzen, Ulrik, Lamers, Daniela, Kronshage, Birgit, Heise, Tim
Publicado 2018

Danegaptide Prevents TGFβ1-Induced Damage in Human Proximal Tubule Epithelial Cells of the Kidney

por Squires, Paul E., Price, Gareth W., Mouritzen, Ulrik, Potter, Joe A., Williams, Bethany M., Hills, Claire E.
Publicado 2021

Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes

por Cliff, Chelsy L., Williams, Bethany M., Chadjichristos, Christos E., Mouritzen, Ulrik, Squires, Paul E., Hills, Claire E.
Publicado 2022